Defence Therapeutics Inc (DTC) Stock Price & News

All values in CAD	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	335.23K	115.60K	316.51K	729.19K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	922.56K	353.71K	964.46K	401.52K
Operating expense	1.42M	599.46K	1.37M	1.16M
Total operating expenses	1.42M	599.46K	1.37M	1.16M
Operating income	-1.42M	-599.46K	-1.37M	-1.16M
Other non operating income	315.48K	-75.71K	-36.17K	-1.75M
EBT including unusual items	-1.16M	-703.00K	-1.52M	-2.96M
EBT excluding unusual items	-1.08M	-703.00K	-1.52M	-2.96M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-1.16M	-703.00K	-1.52M	-2.96M
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	631.00	-
Interest expense	-21.68K	-11.92K	-111.06K	-76.49K
Net interest expenses	-21.68K	-11.92K	-110.43K	-76.49K
Depreciation and amortization charges	19.21K	16.24K	9.28K	9.42K
EBITDA	-1.41M	-589.88K	-1.36M	-1.15M
Gain or loss from assets sale	-	-	-	-

Finance